Dr. Christina Mwachari, MD, MSc, PhD is a physician-scientist and public health researcher with more than 25 years of experience in infectious disease research, epidemiology, and health systems strengthening in Africa. She currently serves as a Principal Research Scientist at the Kenya Medical Research Institute (KEMRI) and as Director of Research and Development (R&D) at CRK Clinical Research Organization, where she leads initiatives focused on advancing clinical research, innovation, and workforce development.
She holds an MBChB from the University of Nairobi, an MSc in Medical Microbiology from the London School of Hygiene and Tropical Medicine, a Master of Public Health in Epidemiology from the University of Washington, and a PhD in Public Health / Epidemiology from Jomo Kenyatta University of Agriculture and Technology (JKUAT).
Dr. Mwachari’s research career began within Kenya’s Ministry of Health before transitioning into senior research and leadership roles at KEMRI and the University of Maryland Programs in Kenya, where she contributed to large-scale public health, laboratory systems strengthening, and implementation programs. Her work has focused on HIV prevention and care, tuberculosis and respiratory diseases, reproductive health, and community-based health interventions.
Throughout her career, she has led and contributed to numerous clinical studies and public health programs supported by organizations including WHO, NIH, PEPFAR, and the Rockefeller Foundation, and she has presented her work at major international scientific meetings such as CROI, the International AIDS Conference, and the IUATLD World Conference on Lung Health.
She has also played an important role in strengthening laboratory systems in Kenya, mentoring more than twenty laboratories toward ISO 15189 accreditation and supervising postgraduate researchers in epidemiology and public health.
Within Amyloidosis Africa, Dr. Mwachari contributes research leadership and scientific guidance, supporting efforts to strengthen evidence generation, research collaboration, and capacity building across African countries.
We advance cardiac amyloidosis care across Africa through collaboration, training, and research. Join us to change the future of heart health and empower local clinicians with knowledge and tools.